跳至主要内容
临床试验/NCT06403670
NCT06403670已完成4 期

The Effects of Dexmedetomidine and Remifentanil on Sedation and Comfort in Non-Operating Room Anesthesia: A Randomized, Double-blind, Controlled Trial

Baskent University Ankara Hospital1 个研究点 分布在 1 个国家目标入组 76 人开始时间: 2022年12月17日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
76
试验地点
1
主要终点
Agitation-Sedation

研究概览

简要总结

Endoscopic retrograde cholangiopancreatography (ERCP) procedure is frequently encountered in non-operating room anesthesia applications (NORA). It is a procedure that requires deep sedation and analgesia in terms of gastroenterologist and patient comfort. Dexmedetomidine, which is increasingly used in NORA applications, comes to the fore because it does not cause respiratory depression, reduces the stress response, and provides hemodynamic stability. This study aims to compare the effects of dexmedetomidine-propofol (DP) and remifentanil-propofol (RP) combinations on hemodynamic stability, rapid recovery, and patient comfort in patients who underwent ERCP.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • Neurological disease,
  • Psychiatric disease,
  • Coronary artery disease,
  • Long-term sedative drug use,
  • Pregnant patients,
  • Known allergy to planned drugs

研究组 & 干预措施

Group Dex

Active Comparator

Group Dex received 0.5 mcg/kg of dexmedetomidine IV for 10 minutes, then dexmedetomidine infusion was started at 0.1-0.7 mcg/kg/h. Propofol 1 mg/kg was administered after waiting for 5 minutes for adequate sedation to develop due to dexmedetomidine's delayed onset of action.

干预措施: Dexmedetomidine (Drug)

Group Remi

Active Comparator

Group RP received remifentanil 0.1 mcg/kg intravenously for 2 minutes, then remifentanil infusion was started at 0.01-0.1 mcg/kg/min. After waiting 2 minutes to develop a sufficient sedation level, 1 mg/kg of propofol was given.

干预措施: Remifentanil (Drug)

结局指标

主要结局

Agitation-Sedation

时间窗: 0 and 5 minutes after ERCP ends

It will be evaluated with a Richmond Agitation-Sedation Scale.

Hemodynamic stability

时间窗: 5, 10, 15, 25, 35. minutes

Mean arterial pressure with non-invasive blood pressure monitoring (mmHg)

次要结局

  • Minimize drug dose(5, 10, 15, 25, 35. minutes)
  • Rapid recovery(30 minutes after ERCP ends)
  • Patient comfort(30 minutes after ERCP ends)

研究者

发起方
Baskent University Ankara Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Uslu

MD, Research assistant

Baskent University Ankara Hospital

研究点 (1)

Loading locations...

相似试验